MedDay is a biotechnology company, which develops new drugs for neurological and psychiatric diseases. It provides MD1003, a solution for the treatment of primary and secondary progressive multiple sclerosis; MD1103, a solution for autism spectrum disorders; and MD1105, a solution for Alzheimer’s disease.
|Employees (est.) (Jun 2021)||41||(-6%)|
MedDay total Funding
MedDay latest funding size
Time since last funding
|5 years ago|
|Sofinnova Partners, Bpifrance Large Venture, Edmond de Rothschild Investment Partners, InnoBio|
MedDay has 226 Twitter Followers. The number of followers has decreased 1.1% month over month and decreased 0.7% quarter over quarter
When was MedDay founded?
MedDay was founded in 2011.
Who are MedDay key executives?
MedDay's key executives are Frédéric Sedel, Catherine Moukheibir and Hermine Cadence.
How many employees does MedDay have?
MedDay has 41 employees.
Who are MedDay competitors?
Competitors of MedDay include ImCheck Therapeutics, Sigilon and Kymera Therapeutics.
Where is MedDay headquarters?
MedDay headquarters is located at 8 Rue Henri Poincaré, Clichy.
Where are MedDay offices?
MedDay has offices in Clichy, Paris and Boston.
How many offices does MedDay have?
MedDay has 3 offices.
Receive alerts for 300+ data fields across thousands of companies